Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Clinical studies and pharmacology research show that adjusting your dose time a little is fine
Tirzepatide has demonstrated sustained weight loss through 72 weeks with minimal regain, establishing its durability
Micro-dosing with the NAD+ Subcutaneous Pen will provide a steady release of NAD+, offering a convenient at-home alternative to IV drips
These factors emphasize the need for strategies to manage costs and engage in insurance negotiations to improve accessibility once the drug becomes available
US$ 22.40
US$ 24.08
US$ 21.69
US$ 22.82
US$ 21.96
US$ 24.74
